Lateral Flow Immunoassay for Furazolidone Point-of-care Testing: Cater to the Call of Saving Time, Labor, and Cost by Coomassie Brilliant Blue Labeling

Jingke Xu,Leina Dou,Sijie Liu,Lihong Su,Xuechi Yin,Jing Ren,Huilan Hu,Daohong Zhang,Jing Sun,Zhanhui Wang,Jianlong Wang
DOI: https://doi.org/10.1016/j.foodchem.2021.129415
IF: 8.8
2021-01-01
Food Chemistry
Abstract:Furazolidone (FZD) and its metabolite called 3-amino-2-oxazolidinone (AOZ) would induce carcinogenic and mutagenic effects to human. In this work, to develop a novel, stable, and simple point of care testing (POCT) with a potential to social applied for FZD detection, we utilized the aspect of protein staining of coomassie brilliant blue (CBB) to exploit a new CBB-LFIA strategy free of NPs. Only one mixing step is needed during the probe manufacturing process, which requires just 2 h and is a great time saving strategy compared with other methods (requiring 4?33 h for probe preparation). Besides, the cost of CBB-LFIA is 300 times lesser than other LFIA with respect to obtaining the label. The developed CBB-LFIA was successfully applied to detect AOZ with a detection limit of 2 ng mL-1, without any influence from other potential interfering compounds. The proposed CBB-LFIA exhibited prominent practical application, and possesses considerable utilization potential in the related field.
What problem does this paper attempt to address?